Skip to main content
Premium Trial:

Request an Annual Quote

Genome BC to Fund Development of Freshwater Fish DNA Library

NEW YORK — Genome British Columbia said on Wednesday that it will provide approximately C$250,000 (US$190,640) over the next two years to fund the development of a reference DNA library for all known freshwater fish species in the Canadian province.

According to Genome BC, the resource — which will include both native and invasive fish species and be assembled by a team led by Fisheries and Oceans Canada scientists Cathryn Abbott and Kristen Westfall — will enable the use of sequenced environmental DNA (eDNA) to develop accurate species lists for a given sampled area.

As part of the effort, the team will use eDNA sampling and the DNA library to survey fish in British Columbia's interior that are protected under Canada's Species at Risk Act in order to map the animals' distributions and detect invasive species.

"Generating highest quality reference data requires a significant investment, and yet this will pay great dividends in the long run," Abbott said in a statement. "These data are an essential backbone for leveraging the promise of eDNA methods for monitoring aquatic environments."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.